Clinical Trial Update: Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completion of a study evaluating zoledronic acid as adjuvant therapy to improve quality of life and reduce skeletal-rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED